Insulin Pumps Market Research Report by Product, Disease Indication, Accessories, Distribution Channel, Region - Global Forecast to 2027

Description

List of Tables

The Global Insulin Pumps Market size was estimated at USD 6,682.30 million in 2021 and expected to reach USD 7,397.03 million in 2022, and is projected to grow at a CAGR 10.87% to reach USD 12,413.08 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Insulin Pumps to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Insulin Pump Supplies & Accessories and Insulin Pumps.

Based on Disease Indication, the market was studied across Type 1 Diabetes and Type 2 Diabetes.

Based on Accessories, the market was studied across Infusion Set Insertion Devices, Infusion Sets, and Insulin Reservoirs.

Based on Distribution Channel, the market was studied across Hospital Pharmacy, Retail Pharmacy, and Sales and Diabetes.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Insulin Pumps market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insulin Pumps Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Insulin Pumps Market, including Abbott Laboratories, Animas Corporation, Bayer AG, Cellnovo Group SA., Cigna Corporation, Dexcom Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Jiangsu Delfu Co. Ltd, Medtronic, Merck KGaA, MicroPort Scientific Corporation, Roche Diagnostics Corporation, Sanofi SA, Sensonic Corporation, SOOIL Developments Co., Tandem Diabetes Care, Inc., Terumo Corporation, Valeritas, Inc., and Ypsomed AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Insulin Pumps Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insulin Pumps Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insulin Pumps Market?
4. What is the competitive strategic window for opportunities in the Global Insulin Pumps Market?
5. What are the technology trends and regulatory frameworks in the Global Insulin Pumps Market?
6. What is the market share of the leading vendors in the Global Insulin Pumps Market?
7. What modes and strategic moves are considered suitable for entering the Global Insulin Pumps Market?

Product Code: MRR-43127F7279BB

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Expanding geriatic population have expanded the need for personalized medicine
  - 5.1.1.2. Increasing healthcare funding and government initiatives to promote diabetes awareness
  - 5.1.1.3. Growing awareness towards efficient diabetes management with insulin delivery devices
- 5.1.2. Restraints
  - 5.1.2.1. Lack of skilled professional for appropriate handling of insulin pump
  - 5.1.2.2. Risk of skin infection or allergic reaction and patient suffering from ketoacidosis
- 5.1.3. Opportunities
  - 5.1.3.1. Advent of artificial intelligence in diabetes care devices
  - 5.1.3.2. Rising initiatives taken by the government
- 5.1.4. Challenges
  - 5.1.4.1. High cost of insulin devices
5.2. Cumulative Impact of COVID-19

6. Insulin Pumps Market, by Product

6.1. Introduction
6.2. Insulin Pump Supplies & Accessories
6.3. Insulin Pumps

7. Insulin Pumps Market, by Disease Indication

7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes

8. Insulin Pumps Market, by Accessories

8.1. Introduction
8.2. Infusion Set Insertion Devices
8.3. Infusion Sets
8.4. Insulin Reservoirs

9. Insulin Pumps Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacy
9.3. Retail Pharmacy
9.4. Sales and Diabetes

10. Americas Insulin Pumps Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Insulin Pumps Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Insulin Pumps Market

12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
- 13.1.1. Quadrants
- 13.1.2. Business Strategy
- 13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
- 13.4.1. Merger & Acquisition
- 13.4.2. Agreement, Collaboration, & Partnership
- 13.4.3. New Product Launch & Enhancement
- 13.4.4. Investment & Funding
- 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

14.1. Abbott Laboratories
14.2. Animas Corporation
14.3. Bayer AG
14.4. Cellnovo Group SA.
14.5. Cigna Corporation
14.6. Dexcom Inc.
14.7. F. Hoffmann-La Roche Ltd.
14.8. Insulet Corporation
14.9. Jiangsu Delfu Co. Ltd
14.10. Medtronic
14.11. Merck KGaA
14.12. MicroPort Scientific Corporation
14.13. Roche Diagnostics Corporation
14.14. Sanofi SA
14.15. Sensonic Corporation
14.16. SOOIL Developments Co.
14.17. Tandem Diabetes Care, Inc.
14.18. Terumo Corporation
14.19. Valeritas, Inc.
14.20. Ypsomed AG

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing